New York S 6393: Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors

Status: REFERRED TO HIGHER EDUCATION (as of 2022-03-03)

State: New York · Session: 2021-2022 · Bill: S 6393

Sponsors: REICHLIN-MELNICK

View New York S 6393 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.